These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of high doses of intravenous methylprednisolone and cyclophosphamide on renal homografts. Zincke H; Woods JE; Holley KE Urology; 1977 Oct; 10(4):301-4. PubMed ID: 335605 [TBL] [Abstract][Full Text] [Related]
23. The use of procarbazine hydrochloride versus cyclophosphamide in donor pretreatment in cadaveric renal transplantation. Zincke H; Woods JE; Roses J; Kimbler RW Mayo Clin Proc; 1976 Nov; 51(11):693-6. PubMed ID: 792579 [TBL] [Abstract][Full Text] [Related]
25. The effect of transfusions and donor pretreatment on canine renal allograft survival. van der Linden CJ; Buurman WA; Vegt PA; Slot HB; Greep JM; Jeekel H J Surg Res; 1981 Oct; 31(4):332-6. PubMed ID: 7026900 [No Abstract] [Full Text] [Related]
26. Prolongation of canine renal allograft survival. A study on the effect of donor pretreatment. van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J Transplantation; 1980 Aug; 30(2):132-4. PubMed ID: 7010708 [TBL] [Abstract][Full Text] [Related]
28. A study on the mechanism of donor pretreatment: effect of procarbazine hydrochloride and methylprednisolone in immunocompetent cells. van der Linden CJ; Buurman WA; Vegt PA; Greep JM; Jeekel J Transplantation; 1981 Jul; 32(1):24-8. PubMed ID: 7022795 [TBL] [Abstract][Full Text] [Related]
29. The effect of high dose steroid and cyclophosphamide on perfused canine renal homografts. Tremann JA; Haines JG; Bleifuss JH; Agodoa LC; Marchioro TL Transplantation; 1975 Jun; 19(6):520-2. PubMed ID: 1094642 [No Abstract] [Full Text] [Related]
30. Letter: Steroids and cyclophosphamide dosage in renal allograft perfusion. Woods JE; Zincke H Transplantation; 1976 Mar; 21(3):260. PubMed ID: 781925 [No Abstract] [Full Text] [Related]
31. A prospective randomized double-blind controlled study of cadaver donor pretreatment with cyclophosphamide in human renal transplantation. Chatterjee SN; Smith R; Fine S; Schulman B; Fine RN Transplant Proc; 1981 Mar; 13(1 Pt 2):709-11. PubMed ID: 7022938 [No Abstract] [Full Text] [Related]
32. In vitro monitoring of cadaver kidney donor pretreatment by lymphocyte culture. Jeffery JR; Guttmann RD; Charpentier B Clin Exp Immunol; 1976 Sep; 25(3):437-41. PubMed ID: 134860 [TBL] [Abstract][Full Text] [Related]
34. The effect and mechanism of pretreatment on organ transplantation. Chen HF; Xiong RC; He QZ; Zhang RA Chin Med J (Engl); 1987 May; 100(5):411-8. PubMed ID: 3115714 [No Abstract] [Full Text] [Related]
35. The importance of donor protection by furosemide and steroids in cadaveric kidney preservation. McCabe R; Stevens LE; Subramanian A; Lattes C; Fitzpatrick HF Proc Clin Dial Transplant Forum; 1973; 3():85-7. PubMed ID: 4619689 [No Abstract] [Full Text] [Related]
36. Pretransplant blood transfusion with cyclophosphamide: efficacious means of prolonging allograft survival. Lagodzinski Z; Gorski A Folia Biol (Praha); 1991; 37(1):21-6. PubMed ID: 2070885 [TBL] [Abstract][Full Text] [Related]
37. Renal donor pretreatment with cytotoxic agents: immunologically ineffective and damaging to the graft. Burleson RL; Jones DB; Yenikomshian A; DeVoe C; DeRito J Transplant Proc; 1977 Sep; 9(3):1591-6. PubMed ID: 331594 [TBL] [Abstract][Full Text] [Related]